羊膜の世界市場：業界動向、シェア、規模、成長、機会、予測（2022年～2027年）

世界の羊膜の市場規模は、2021年に12億9,000万米ドルとなり、2022年～2027年の間に9.4％のCAGRで成長し、2027年までに22億2,000万米ドルに達すると予測されています。

羊膜は角膜移植の際に世界中で広く使用されており、角膜手術件数の増加や高齢者人口の増加が、市場の成長を強化する重要な要因の一つとなっています。また、美容整形手術や再建手術にも羊膜が広く使用されるようになってきています。さらに、幹細胞や再生医療の分野では、研究開発（R&D）活動への資金援助が継続的に増加しており、良好な市場の見通しを生み出しています。

当レポートでは、世界の羊膜市場について調査分析し、市場概要、セグメント別・地域別の市場分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の羊膜市場

• 市場概要
• 市場実績
• COVID-19の影響

第6章 市場の内訳：製品別

• 凍結保存羊膜
• 凍結乾燥羊膜

第7章 市場の内訳：用途別

• 外科的創傷
• 眼科
• その他

第8章 市場の内訳：エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック
• 研究センター・研究所

第9章 市場の内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場の内訳：国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Amnio Technology LLC
  • Amniox Medical Inc.(TissueTech Inc.)
  • Genesis Biologics
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corporation
  • Katena Products Inc.
  • MiMedx Group
  • Next Biosciences
  • Skye Biologics Holdings LLC
  • Smith & Nephew plc
  • Surgenex LLC
  • Ventris Medical LLC
  • Wright Medical Group N.V.(Stryker B.V.)

List of Figures

• Figure 1: Global: Amniotic Membrane Market: Major Drivers and Challenges
• Figure 2: Global: Amniotic Membrane Market: Sales Value (in Million US$), 2016-2021
• Figure 3: Global: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 4: Global: Amniotic Membrane Market: Breakup by Product (in %), 2021
• Figure 5: Global: Amniotic Membrane Market: Breakup by Application (in %), 2021
• Figure 6: Global: Amniotic Membrane Market: Breakup by End User (in %), 2021
• Figure 7: Global: Amniotic Membrane Market: Breakup by Region (in %), 2021
• Figure 8: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 9: Global: Amniotic Membrane (Cryopreserved Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 10: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 11: Global: Amniotic Membrane (Lyophilization Amniotic Membrane) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 12: Global: Amniotic Membrane (Surgical Wounds) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 13: Global: Amniotic Membrane (Surgical Wounds) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 14: Global: Amniotic Membrane (Ophthalmology) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 15: Global: Amniotic Membrane (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 16: Global: Amniotic Membrane (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 17: Global: Amniotic Membrane (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 18: Global: Amniotic Membrane (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 19: Global: Amniotic Membrane (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 20: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 21: Global: Amniotic Membrane (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 22: Global: Amniotic Membrane (Specialized Clinics) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 23: Global: Amniotic Membrane (Specialized Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 24: Global: Amniotic Membrane (Research Centers and Laboratory) Market: Sales Value (in Million US$), 2016 & 2021
• Figure 25: Global: Amniotic Membrane (Research Centers and Laboratory) Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 26: North America: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 27: North America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 28: United States: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 29: United States: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 30: Canada: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 31: Canada: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 32: Asia-Pacific: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 33: Asia-Pacific: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 34: China: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 35: China: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 36: Japan: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 37: Japan: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 38: India: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 39: India: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 40: South Korea: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 41: South Korea: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 42: Australia: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 43: Australia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 44: Indonesia: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 45: Indonesia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 46: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 47: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 48: Europe: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 49: Europe: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 50: Germany: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 51: Germany: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 52: France: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 53: France: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 54: United Kingdom: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 55: United Kingdom: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 56: Italy: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 57: Italy: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 58: Spain: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 59: Spain: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 60: Russia: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 61: Russia: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 62: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 63: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 64: Latin America: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 65: Latin America: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 66: Brazil: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 67: Brazil: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 68: Mexico: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 69: Mexico: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 70: Others: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 71: Others: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 72: Middle East and Africa: Amniotic Membrane Market: Sales Value (in Million US$), 2016 & 2021
• Figure 73: Middle East and Africa: Amniotic Membrane Market: Breakup by Country (in %), 2021
• Figure 74: Middle East and Africa: Amniotic Membrane Market Forecast: Sales Value (in Million US$), 2022-2027
• Figure 75: Global: Amniotic Membrane Industry: SWOT Analysis
• Figure 76: Global: Amniotic Membrane Industry: Value Chain Analysis
• Figure 77: Global: Amniotic Membrane Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Amniotic Membrane Market: Key Industry Highlights, 2021 and 2027
• Table 2: Global: Amniotic Membrane Market Forecast: Breakup by Product (in Million US$), 2022-2027
• Table 3: Global: Amniotic Membrane Market Forecast: Breakup by Application (in Million US$), 2022-2027
• Table 4: Global: Amniotic Membrane Market Forecast: Breakup by End User (in Million US$), 2022-2027
• Table 5: Global: Amniotic Membrane Market Forecast: Breakup by Region (in Million US$), 2022-2027
• Table 6: Global: Amniotic Membrane Market: Competitive Structure
• Table 7: Global: Amniotic Membrane Market: Key Players

The global amniotic membrane market reached a value of US$ 1,290 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,220 Million by 2027, exhibiting a CAGR of 9.4% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The amniotic membrane (AM) forms the innermost layer of the placenta that is mainly composed of an epithelial monolayer, acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity, which is filled with amniotic liquid and assists in healing wounds and protecting against infection. It has anti-inflammatories, anti-bacterial, anti-viral, immunological, anti-angiogenic, and proapoptotic properties. As it also aids in preventing the delivery of nutrients and oxygen to cancer cells and consequently interferes with tumor angiogenesis, growth, and metastasis, AM finds wide applications in oncology across the globe.

Amniotic Membrane Market Trends:

• There is currently a rise in the number of corneal surgeries on account of their ability to reduce pain, restore vision, and improve the appearance of a damaged or diseased cornea. This, along with the increasing geriatric population, represents one of the key factors strengthening the growth of the market. AMs assist in enhancing epithelialization, reinforcing adhesion of basal epithelial cells, maintaining epithelial phenotype, and modulating the proliferation of normal cornea, conjunctivital and limbal fibroblast. As they also prevent apoptosis and inhibit scarring, inflammation, and neovascularization, they are widely employed during corneal transplants around the world. Besides this, AMs are relatively cost-effective compared to xenografts and allografts. Consequently, they find extensive applications in a rising number of cosmetic and reconstructive surgeries worldwide. Furthermore, there is a continuous increase in the funding for research and development (R&D) activities in the field of stem cell and regenerative medicine. This, coupled with a rapid increase in the number of surgeries, is creating a favorable market outlook. Other factors, including growing donations of the placenta and rising demand for tissue-based products for treating surgical wounds, are driving the market.

Key Market Segmentation:

• IMARC Group provides an analysis of the key trends in each sub-segment of the global amniotic membrane market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

• Cryopreserved Amniotic Membrane
• Lyophilization Amniotic Membrane

Breakup by Application:

• Surgical Wounds
• Ophthalmology
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Research Centers and Laboratory

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

• The competitive landscape of the industry has also been examined along with the profiles of the key players being Amnio Technology LLC, Amniox Medical Inc. (TissueTech Inc.), Genesis Biologics, Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corporation, Katena Products Inc., MiMedx Group, Next Biosciences, Skye Biologics Holdings LLC, Smith & Nephew plc, Surgenex LLC, Ventris Medical LLC, and Wright Medical Group N.V. (Stryker B.V.).

Key Questions Answered in This Report:

• How has the global amniotic membrane market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global amniotic membrane market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global amniotic membrane market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Amniotic Membrane Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Cryopreserved Amniotic Membrane
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Lyophilization Amniotic Membrane
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Application

• 7.1 Surgical Wounds
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Ophthalmology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Specialized Clinics
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Research Centers and Laboratory
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Amnio Technology LLC
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Amniox Medical Inc. (TissueTech Inc.)
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Genesis Biologics
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Human Regenerative Technologies LLC
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Integra LifeSciences Holdings Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Katena Products Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 MiMedx Group
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Next Biosciences
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Skye Biologics Holdings LLC
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Smith & Nephew plc
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Surgenex LLC
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Ventris Medical LLC
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Wright Medical Group N.V. (Stryker B.V.)
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 SWOT Analysis